MedPage Today) — Topline data showed that an investigational gene therapy slowed Huntington’s disease progression and met its primary endpoint in a pivotal trial, uniQure Biopharma announced Wednesday.
A high-dose version of the treatment, known…
Investigational Gene Therapy Slows Huntington’s Disease Progression

Leave a Comment Leave a Comment